Tore Persson - Concepedia

Author

Tore Persson

AstraZeneca (Sweden)

Also Known As

Eva Pettersson, Persson, Tore, T Persson, T. PERSSON, T. Persson, TORE PERSSON, Tore B. Persson, Tore Persson

Publications

7.3K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)University of Alberta Helsinki University Hospital Lund University Western University

About

Tore Persson is an author at AstraZeneca (Sweden) specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1.7K
2	Allergy	3	3	68
3	Public Health	2	2	83
4	Allergy Medicine	2	2	37
5	Engineering	1	1	66

Tore Persson

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Comparison of a β<sub>2</sub>-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma Tari Haahtela, Markku Järvinen, T Kava, New England Journal of Medicine	1991	789
Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma Tari Haahtela, Markku Järvinen, T Kava, New England Journal of Medicine	1994	746
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease Paul Rutgeerts, Robert Löfberg, H Malchow, New England Journal of Medicine	1994	602
Oral Budesonide for Active Crohn's Disease Gordon R. Greenberg, Brian G. Feagan, François Martin, New England Journal of Medicine	1994	566
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease Ole Østergaard Thomsen, Antoine Cortot, D P Jewell, New England Journal of Medicine	1998	331
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease Massimo Campieri, Alexander C. Ferguson, W F Doe, Gut	1997	327
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease G Hellers, Antoine Cortot, Derek P. Jewell, Gastroenterology GastroenterologyOral BudesonideClinical GastroenterologyUlcerative ColitisMedicine	1999	298
Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group GR Greenberg, BG Feagan, Florian Martin, Gastroenterology InflammationMaintenance TreatmentGastrointestinal PharmacologyGastroenterologyOral Budesonide	1996	293
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis Stefan Lindgren, Lars M. Flood, Anders Kilander, European Journal of Gastroenterology & Hepatology	1998	273
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Robert Löfberg, Paul Rutgeerts, H Malchow, Gut	1996	212

Page 1